NEW YORK (GenomeWeb News) – Signal Genetics today said that Arkansas Blue Cross Blue Shield will cover the company's molecular assay for multiple myeloma.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.